Literature DB >> 24200746

Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration.

Fabio R Formiga1, Beatriz Pelacho2, Elisa Garbayo1, Izaskun Imbuluzqueta1, Paula Díaz-Herráez1, Gloria Abizanda2, Juan J Gavira2, Teresa Simón-Yarza1, Edurne Albiasu2, Esther Tamayo1, Felipe Prósper3, Maria J Blanco-Prieto4.   

Abstract

Acidic fibroblast growth factor (FGF1) and neuregulin-1 (NRG1) are growth factors involved in cardiac development and regeneration. Microparticles (MPs) mediate cytokine sustained release, and can be utilized to overcome issues related to the limited therapeutic protein stability during systemic administration. We sought to examine whether the administration of microparticles (MPs) containing FGF1 and NRG1 could promote cardiac regeneration in a myocardial infarction (MI) rat model. We investigated the possible underlying mechanisms contributing to the beneficial effects of this therapy, especially those linked to endogenous regeneration. FGF1- and NRG1-loaded MPs were prepared using a multiple emulsion solvent evaporation technique. Seventy-three female Sprague-Dawley rats underwent permanent left anterior descending coronary artery occlusion, and MPs were intramyocardially injected in the peri-infarcted zone four days later. Cardiac function, heart tissue remodeling, revascularization, apoptosis, cardiomyocyte proliferation, and stem cell homing were evaluated one week and three months after treatment. MPs were shown to efficiently encapsulate FGF1 and NRG1, releasing the bioactive proteins in a sustained manner. Three months after treatment, a statistically significant improvement in cardiac function was detected in rats treated with growth factor-loaded MPs (FGF1, NRG1, or FGF1/NRG1). The therapy led to inhibition of cardiac remodeling with smaller infarct size, a lower fibrosis degree and induction of tissue revascularization. Cardiomyocyte proliferation and progenitor cell recruitment were detected. Our data support the therapeutic benefit of NRG1 and FGF1 when combined with protein delivery systems for cardiac regeneration. This approach could be scaled up for use in pre-clinical and clinical studies.
© 2013.

Entities:  

Keywords:  Cardiac repair; FGF1; Myocardial infarction; NRG1; PLGA microparticles

Mesh:

Substances:

Year:  2013        PMID: 24200746     DOI: 10.1016/j.jconrel.2013.10.034

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  36 in total

1.  A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle.

Authors:  Federica Santoro; Makoto Sahara
Journal:  Ann Transl Med       Date:  2015-10

2.  Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.

Authors:  Karl Toischer; Wuqiang Zhu; Mark Hünlich; Belal A Mohamed; Sara Khadjeh; Sean P Reuter; Katrin Schäfer; Deepak Ramanujam; Stefan Engelhardt; Loren J Field; Gerd Hasenfuss
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

Review 3.  Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine.

Authors:  Qi-Ling Yuan; Yin-Gang Zhang; Qian Chen
Journal:  Anat Rec (Hoboken)       Date:  2019-06-17       Impact factor: 2.064

Review 4.  Engineered circulatory scaffolds for building cardiac tissue.

Authors:  Shixing Huang; Yang Yang; Qi Yang; Qiang Zhao; Xiaofeng Ye
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 5.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

Review 6.  Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration.

Authors:  Jan Aam Kamps; Guido Krenning
Journal:  World J Cardiol       Date:  2016-02-26

7.  Micro- and Nanoparticles for Treating Cardiovascular Disease.

Authors:  S Suarez; A Almutairi; K L Christman
Journal:  Biomater Sci       Date:  2015-04       Impact factor: 6.843

8.  Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.

Authors:  Seyed Javad Hoseini; Hamed Ghazavi; Fatemeh Forouzanfar; Baratali Mashkani; Ahmad Ghorbani; Elahe Mahdipour; Faezeh Ghasemi; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  DNA Cell Biol       Date:  2017-03-10       Impact factor: 3.311

9.  Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue Engineering and Therapy.

Authors:  Anwarul Hasan; Renae Waters; Boustany Roula; Rahbani Dana; Seif Yara; Toubia Alexandre; Arghya Paul
Journal:  Macromol Biosci       Date:  2016-03-08       Impact factor: 4.979

Review 10.  Fibrous scaffolds for building hearts and heart parts.

Authors:  A K Capulli; L A MacQueen; Sean P Sheehy; K K Parker
Journal:  Adv Drug Deliv Rev       Date:  2015-12-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.